戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 isk factors (eg, adverse pregnancy outcomes, premature menopause).
2 ature menopause and 887 (4.5%) with surgical premature menopause.
3 NMT3A CHIP was significantly associated with premature menopause.
4 mature menopause and 644 (0.4%) had surgical premature menopause.
5  carriers may have an increased incidence of premature menopause.
6 ightened cardiovascular risk associated with premature menopause.
7 RSO) that avoids detrimental consequences of premature menopause.
8  but smaller and nonsignificant for surgical premature menopause.
9 ), postmenopausal hormone therapy (11%), and premature menopause (1%).
10  1125 women were diagnosed with AAA, 134 had premature menopause (11.9%), 93 underwent surgical inter
11 at menopause 43.7 +/- 8.6 years), women with premature menopause (29.3%) were younger at enrollment (
12 ce, 8.78/1000 woman-years) (difference vs no premature menopause, +3.08/1000 woman-years [95% CI, 2.0
13 al or perimenopausal, younger than 40 years (premature menopause), 40-44 years (early menopause), 45-
14 e, 11.27/1000 woman-years) (difference vs no premature menopause, +5.57/1000 woman-years [95% CI, 2.4
15 MD include age, previous fragility fracture, premature menopause, a family history of hip fracture, a
16 vascular disease was higher in women who had premature menopause (age <40 years; HR 1.55, 95% CI 1.38
17                          The associations of premature menopause (age at menopause of <40 years) and
18         Associations were larger for natural premature menopause (all CHIP: odds ratio, 1.73 [95% CI,
19   Just under 10,000 (9.4%) women experienced premature menopause and 22,240 (22%) experienced early m
20 , 59.9 [5.4] years), 4904 (3.4%) had natural premature menopause and 644 (0.4%) had surgical prematur
21 606 women, including 418 (2.1%) with natural premature menopause and 887 (4.5%) with surgical prematu
22 ts can impair ovarian function, resulting in premature menopause and associated long-term health effe
23  examined sex-specific risk factors, such as premature menopause and early menarche, with risk of AAA
24                             Counseling about premature menopause and fertility changes is an overlook
25  analyses considered natural versus surgical premature menopause and gene-specific CHIP subtypes.
26 adiotherapy, and radical surgery, can induce premature menopause and infertility in hundreds of thous
27 on analyses tested the joint associations of premature menopause and LTL with incident coronary arter
28 e women at risk for acute ovarian failure or premature menopause and men at risk for temporary or per
29 There was no significant association between premature menopause and risk of AAA amongst women who ha
30 motherapy, adjuvant; menstruation disorders; premature menopause, and amenorrhea.
31 oses were at risk for acute ovarian failure, premature menopause, and small-for-gestational-age offsp
32 ramifications involved with the induction of premature menopause as well as potential benefits necess
33 enopause (at age < 47 years), 33 of whom had premature menopause (at age < 40 years), as well as amon
34                         Natural and surgical premature menopause (before age 40 years) were associate
35 re age 40 without oophorectomy) and surgical premature menopause (bilateral oophorectomy before age 4
36 ay more limited features of aging, including premature menopause; both syndromes involve genome insta
37 he chronic effects of cancer (pain, fatigue, premature menopause, depression/anxiety), monitoring for
38 , peripheral neuropathy, delayed menarche or premature menopause, Down syndrome, Turner syndrome, Wil
39 opause and a > or = 9-fold increased risk of premature menopause due to an FMR1 premutation, under a
40 such as hypertensive disorders of pregnancy, premature menopause (especially primary ovarian insuffic
41                                              Premature menopause, especially natural premature menopa
42 strongest before age 60 years for women with premature menopause (HR 1.88, 1.62-2.20; p<0.0001) and e
43 P < .001), and 49 women (7.6%) with surgical premature menopause (incidence, 11.27/1000 woman-years)
44 utcome occurred in 5415 women (3.9%) with no premature menopause (incidence, 5.70/1000 woman-years),
45  woman-years), 292 women (6.0%) with natural premature menopause (incidence, 8.78/1000 woman-years) (
46                                              Premature menopause is a risk factor for accelerated car
47                                              Premature menopause is an independent risk factor for ca
48                                      Whether premature menopause is associated with CHIP is unknown.
49      Premature menopause, especially natural premature menopause, is independently associated with CH
50 ewed the frequency of acute ovarian failure, premature menopause, live birth, stillbirth, spontaneous
51 abetes (without subsequent type 2 diabetes), premature menopause (&lt;40 years), early menopause (<45 ye
52                        This study finds that premature menopause may be an important risk factor for
53 f PM and PO is low, but the complications of premature menopause may be significant, and few studies
54                                     Although premature menopause may occur in a small proportion of p
55                                      Natural premature menopause may serve as a risk signal for predi
56 ardiovascular disease risk, with timing (eg, premature menopause), mechanism, and symptoms of menopau
57                                              Premature menopause (menopause at younger than 40 years)
58                                      Natural premature menopause (menopause before age 40 without oop
59           Family history of premature ASCVD, premature menopause, metabolic syndrome, chronic kidney
60                 Postmenopausal women without premature menopause served as the reference group.
61    This cohort study assesses whether adding premature menopause status to pooled cohort equations im
62 early menopause and suggest that the risk of premature menopause to fragile X-premutation carriers ma
63  a > or = 26-fold increased risk of familial premature menopause, under a less probable model in whic
64 ausal women with versus without a history of premature menopause was 8.8% versus 5.5% (P<0.001), resp
65 opause at age 40 or more years compared with premature menopause was associated with a 50% decreased
66 resistance, and hormone replacement therapy, premature menopause was associated with an increased lik
67                                              Premature menopause was associated with increased risk o
68                                              Premature menopause was defined as natural or surgical m
69              After multivariable adjustment, premature menopause was independently associated with CH
70 surface area (which has been associated with premature menopause) was associated with a significantly
71 or the primary outcome, natural and surgical premature menopause were associated with hazard ratios o
72                                   Women with premature menopause were more likely to be overweight, B
73 oking history (n = 19,286), 2148 (11.1%) had premature menopause, which was associated with greater r
74 d genomic instability, in the association of premature menopause with cardiovascular disease.
75 ogistic regression tested the association of premature menopause with CHIP, adjusted for age, race, t
76 en with a BRCA1/2 pathogenic variant undergo premature menopause with potential short- and long-term